×
About 64,483 results

ALLMedicine™ Influenza Center

Research & Reviews  21,227 results

Postmarketing safety surveillance of high-dose quadrivalent influenza vaccine: Reports ...
https://doi.org/10.1016/j.vaccine.2021.12.070
Vaccine Woo EJ, Moro PL

Jan 16th, 2022 - On November 4, 2019, the Food and Drug Administration approved high-dose quadrivalent influenza vaccine (Fluzone High-Dose Quadrivalent; QIV-HD) for active immunization for the prevention of influenza disease in individuals 65 years of age and old...

Immune interference revisited: Impact of live-attenuated influenza vaccine prior to yel...
https://doi.org/10.1016/j.vaccine.2021.12.031
Vaccine Blyth DM, Liang Z et. al.

Jan 16th, 2022 - During routine mass live-attenuated influenza vaccination (LAIV) for military personnel, emergent deployment for Ebola humanitarian assistance (OUA) required mass yellow fever vaccination (YF17D), often < 4-weeks recommended timing post-LAIV-trigg...

Performance and usability evaluation of novel intradermal injection device Immucise™ an...
https://doi.org/10.1016/j.vaccine.2021.12.061
Vaccine Shimizu S, Tanaka R et. al.

Jan 16th, 2022 - Under the pandemic situation, there is an urgent need to produce and acquire sufficient quantities of prophylactic vaccines. It becomes important to devise a way to achieve reliable immunity with lower doses to distribute limited supplies of vacci...

Does influenza vaccination help reduce incidence of COVID-19 infection among hospital e...
https://doi.org/10.1097/MD.0000000000028479
Medicine Shosha SH, Ajlan DI et. al.

Jan 15th, 2022 - To facilitate the understanding of the interaction between severe acute respiratory syndrome coronavirus 2 causing the corona virus disease 2019 (COVID-19) and other pathogens causing respiratory system affection we investigated the effect of infl...

From high-throughput to therapeutic: host-directed interventions against influenza viru...
https://doi.org/10.1016/j.coviro.2021.12.014
Current Opinion in Virology; Trimarco JD, Heaton NS

Jan 15th, 2022 - Influenza viruses are simultaneously supported and antagonized by factors within the host cell. This close relationship is the theoretical basis for future antivirals that target the host rather than the virus itself, a concept termed host-directe...

see more →

Guidelines  38 results

Recommendations for Prevention and Control of Influenza in Children, 2021-2022.
https://doi.org/10.1542/peds.2021-053745
Pediatrics

Sep 9th, 2021 - This technical report accompanies the recommendations of the American Academy of Pediatrics for the routine use of the influenza vaccine and antiviral medications in the prevention and treatment of influenza in children during the 2021-2022 season...

Recommendations for Prevention and Control of Influenza in Children, 2021-2022.
https://doi.org/10.1542/peds.2021-053744
Pediatrics

Sep 9th, 2021 - Recommendations for Prevention and Control of Influenza in Children, 2021-2022.|2021| ,|therapeutic use,drug therapy,prevention & control,

Recommendations for Prevention and Control of Influenza in Children, 2019-2020.
https://doi.org/10.1542/peds.2019-2478
Pediatrics

Sep 4th, 2019 - This statement updates the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccines and antiviral medications in the prevention and treatment of influenza in children during the 2019-2020 season. The American...

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713402
MMWR. Recommendations and Reports : Morbidity and Mortali... Grohskopf LA, Alyanak E et. al.

Aug 24th, 2019 - This report updates the 2018-19 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2018;67[No. RR-3]). Routine annual influenza vaccinat...

Seasonal influenza vaccine guidelines, 2018-2019.
https://doi.org/10.1097/01.NURSE.0000546461.18898.0b
Nursing Wiley SK

Jan 3rd, 2019 - Seasonal influenza vaccine guidelines, 2018-2019.|2019|Wiley SK,|nursing,administration & dosage,prevention & control,

see more →

Drugs  317 results see all →

Clinicaltrials.gov  821 results

Immunogenicity and Safety of Three Dose Levels of OVX836 Candidate Vaccine Against Influenza in Healthy Volunteers.
https://clinicaltrials.gov/ct2/show/NCT05060887

Jan 13th, 2022 - This trial is a Phase 2a, randomized, double-blind, controlled study in 138 adult subjects to compare the immunogenicity and the safety of OVX836 influenza vaccine at two dose levels (300μg and 480μg) to lower dose level (180µg) and to placebo. On...

Long-term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza Challenge
https://clinicaltrials.gov/ct2/show/NCT02511002

Jan 11th, 2022 - Circulating anti-influenza antibodies are an important factor in predicting clinical illness and severity in those infected with influenza. Specific antibodies against influenza include proteins targeting hemagglutinin (HA) and neuraminidase (NA)....

An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red...
https://clinicaltrials.gov/ct2/show/NCT04717414

Jan 11th, 2022 - Permitted Concomitant Medications and Procedures Subjects are receiving a JAK2 inhibitor for the treatment of MPN-associated MF that is approved in the country where the study is being conducted. JAK2 inhibitors are to be used according to their r...

Screening for LID Clinical Studies Unit Healthy Volunteer Protocols
https://clinicaltrials.gov/ct2/show/NCT01386424

Jan 6th, 2022 - The high morbidity and mortality associated with both pandemic and seasonal influenza and the anticipation for future influenza pandemics puts influenza front and center in infectious disease research. Because the natural history and pathogenesis ...

Clinical Trial of Quadrivalent Influenza Virus Split Vaccine in Population Aged 3-8 Years
https://clinicaltrials.gov/ct2/show/NCT05138705

Jan 6th, 2022 - To evaluate the safety and immunogenicity of quadrivalent influenza virus split vaccine in healthy population aged 3-8 years following different immunization procedures, and the participants randomized to receive two injections of 0.5 mL quadrival...

see more →

News  3,366 results

Diverse Needs of Post-COVID-19 Patients Managed In or Out of Hospital
https://www.medscape.com/viewarticle/966536

Jan 14th, 2022 - NEW YORK (Reuters Health) - A large study from the UK shows that patients who recover from COVID-19, whether managed in or outside the hospital, often seek care from their primary-care provider for multiple lingering problems - and those problems ...

 'Dramatic' Fall in Hospital Admissions for Childhood Infections During Pandemic
https://www.medscape.com/viewarticle/966523

Jan 13th, 2022 - Rates of hospital admissions for common and severe childhood infections in England underwent a "substantial" reduction in the first 12 months of COVID-19, a study found. Cases of influenza, bronchiolitis, and meningitis dipped as pandemic lockdown...

Flu Vax No Shot in the Arm Against COVID for Healthcare Workers
https://www.medpagetoday.com/infectiousdisease/vaccines/96583

Jan 10th, 2022 - Vaccination against influenza did not appear to help protect healthcare workers from getting COVID-19 early in the pandemic, Danish researchers found. There was no difference in odds of COVID hospitalization (adjusted OR 0.91, 95% CI 0.49-1.67, P=...

New Bird Flu Has Higher Risk of Spread to Humans: Animal Health Director
https://www.medscape.com/viewarticle/966084

Jan 6th, 2022 - PARIS (Reuters) - A wave of bird flu in Asia and Europe has a greater risk of spreading to humans because of a high number of variants, the World Organisation for Animal Health (OIE) said. The spread of highly pathogenic avian influenza has raised...

Pfizer, BioNTech to Develop Shingles Shot, After COVID-19 Vaccine Success
https://www.medscape.com/viewarticle/966073

Jan 6th, 2022 - (Reuters) - Pfizer Inc and Germany's BioNTech SE will develop an mRNA-based vaccine for the prevention of viral infection shingles, collaborating for the third time after the success of their COVID-19 vaccine based on the same technology. Pfizer p...

see more →

Patient Education  24 results see all →